Physician Assistant in White Sulphur Springs, MT Accepting Medicare
2 Physician Assistant nurses found. Showing 1 - 2
 Ronald Hamm, PA Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 16 W Main St, White Sulphur Springs, MT 59645 Phone: 406-547-3321 Fax: 406-547-3298 |
David S Meissner, PA C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 16 W Main St, White Sulphur Springs, MT 59645 Phone: 406-547-3321 Fax: 406-547-3298 |
News Archive
Sentrx achieves Gold Partner status in OPN
Sentrx, a leading provider of drug safety services to the life sciences industry, has achieved Gold Partner status in the Oracle PartnerNetwork. Sentrx will provide life sciences companies with support for Oracle clinical solutions, emphasizing its expertise in drug safety systems, safety data management and adverse event reporting software, processes and consulting expertise.
Simple eye scan can detect early signs of diabetes-related nerve damage
Could a simple eye scan detect early signs of diabetes-related nerve damage? Recent research toward developing such a test is the topic of a special article in Optometry and Vision Science, official journal of the American Academy of Optometry.
Research uncovers test to identify iMCD patients with superior response to FDA-approved treatment
New research has uncovered a precision medicine test using blood proteins to identify a novel patient subgroup of idiopathic multicentric Castleman disease (iMCD), a rare blood disorder, who are more likely to respond to siltuximab, the only FDA approved treatment for the disease.
Research opens up new ways to detect, inhibit cancer spread
Clusters of circulating cells commonly found in the blood of cancer patients have long been the subject of research on cancer. These clusters have been regarded for more than 50 years as malignant cells that have broken off from the primary tumor, spreading cancer to other parts of the body.
Mesoblast receives EMA clearance to initiate Revascor Phase 2 trial for heart attacks
Global regenerative medicine company, Mesoblast Limited, today announced that it had received clearance from the European Medicines Agency (EMA) to begin a 225-patient multi-center Phase 2 clinical trial in Europe for its lead cardiovascular product Revascor(TM) in conjunction with angioplasty and stent procedures to prevent heart failure after a major heart attack.
› Verified 9 days ago